Literature DB >> 10712589

A diminished activation capacity of the interferon-inducible protein kinase PKR in human T lymphocytes.

S Li1, K Nagai, A E Koromilas.   

Abstract

The double-stranded (ds) RNA activated protein kinase PKR is an interferon (IFN)-inducible serine/threonine protein that regulates protein synthesis through the phosphorylation of the alpha subunit of translation initiation factor 2 (eIF-2alpha). PKR activation in cells is induced by virus infection or treatment with dsRNA and is modulated by a number of viral and cellular factors. To better understand the mechanisms of PKR action we have analyzed and compared the mode of PKR activation in a number of cell lines of different histological origin. Here we show that PKR activation and phosphorylation of eIF-2alpha are both diminished in various virus-transformed and nontransformed human T cells. Priming of T cells with IFN does not restore PKR activation. In vitro kinase assays show that the diminished PKR activation in T cells correlates with the presence of a 60-kDa (p60) phosphoprotein coimmunoprecipitated with PKR. P60 is absent from PKR immunoprecipitates from non T cells. Incubation of active PKR with T cell extracts results in inhibition of PKR autophosphorylation, which is proportional to the amount of phosphorylated p60 in the kinase reactions. Treatment of T cells with proteasome inhibitors or incubation of PKR immunoprecipitates with phosphatase inhibitors does not restore PKR activation. However, phosphorylation of p60 is enhanced upon treatment with the phosphatase inhibitor microcystin. These data show that the impaired activation capacity of PKR in human T cells is exerted at the post-translational levels in a manner that is independent of cell transformation or virus infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10712589     DOI: 10.1046/j.1432-1327.2000.01134.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

1.  Constant IFNgamma mRNA to protein ratios in cord and adult blood T cells suggests regulation of IFNgamma expression in cord blood T cells occurs at the transcriptional level.

Authors:  A Kumar Gupta; C Rusterholz; W Holzgreve; S Hahn
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

2.  The cellular TAR RNA binding protein, TRBP, promotes HIV-1 replication primarily by inhibiting the activation of double-stranded RNA-dependent kinase PKR.

Authors:  Viraj R Sanghvi; Laura F Steel
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

3.  Regulatory RNA induces the production of IFN-gamma, but not IL-4 in human lymphocytes: role of RNA-dependent protein kinase (PKR) and NF-kappaB.

Authors:  Fernando L De Lucca; Valeria S F Sales; Liliana R Souza; Joana M Murad; Maria Angelica E Watanabe
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

4.  Control of alpha subunit of eukaryotic translation initiation factor 2 (eIF2 alpha) phosphorylation by the human papillomavirus type 18 E6 oncoprotein: implications for eIF2 alpha-dependent gene expression and cell death.

Authors:  Shirin Kazemi; Stavroula Papadopoulou; Suiyang Li; Qiaozhu Su; Shuo Wang; Akihiko Yoshimura; Greg Matlashewski; Thomas E Dever; Antonis E Koromilas
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

5.  Evidence for the involvement of the RNA-dependent protein kinase (PKR) in the induction of human cytotoxic T lymphocytes against a synthetic peptide of HIV-1 by regulatory RNA.

Authors:  Fernando L De Lucca; Valeria S F Sales; Liliana R Souza; Maria Angelica E Watanabe
Journal:  Mol Cell Biochem       Date:  2002-09       Impact factor: 3.396

Review 6.  Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action.

Authors:  M A García; J Gil; I Ventoso; S Guerra; E Domingo; C Rivas; M Esteban
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

7.  Co-expression of miRNA targeting the expression of PERK, but not PKR, enhances cellular immunity from an HIV-1 Env DNA vaccine.

Authors:  Adam K Wheatley; Marit Kramski; Marina R Alexander; Jesse G Toe; Rob J Center; Damian F J Purcell
Journal:  PLoS One       Date:  2011-03-25       Impact factor: 3.240

8.  mTORC1 and CK2 coordinate ternary and eIF4F complex assembly.

Authors:  Valentina Gandin; Laia Masvidal; Marie Cargnello; Laszlo Gyenis; Shannon McLaughlan; Yutian Cai; Clara Tenkerian; Masahiro Morita; Preetika Balanathan; Olivier Jean-Jean; Vuk Stambolic; Matthias Trost; Luc Furic; Louise Larose; Antonis E Koromilas; Katsura Asano; David Litchfield; Ola Larsson; Ivan Topisirovic
Journal:  Nat Commun       Date:  2016-04-04       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.